Medtronic, Inc.

Medtronics, Inc.

Medtronic Cryocath LP

Yong Kyun Cho

Mark K Erickson

Todd Jon Sheldon

Tommy Dean Bennett

Wade M Demmer

Todd M Zielinski

Luc Roland Mongeon

Douglas A Hettrick

Vincent E Splett

Saul E Greenhut

H Toby Markowitz

Eduardo N Warman

Shantanu Sarkar

Catherine R Condie

Robert T Taepke

Donald N Jensen

Karen J Kleckner

John E Burnes

Michael F Hess

Aleksandre T Sambelashvili

Charles P Sperling

Xusheng Zhang

Avram Scheiner

John C Rueter

David A Igel

Maneesh Shrivastav

Barbro M Kjellstrom

Jodi Zilinski

James D Reinke

Can Cinbis

Jonathan L Kuhn

Vinod Sharma

David A Anderson

Michael D Eggen

Richard J O'Brien

Robert A Corey

Sameh Sowelam

Scott W Davie

Donna M Salmi

David R Bloem

Ron Kalin

Harry Stone

Jeffrey M Gillberg

John Louis Sommer

Rodolphe Katra

Thomas J Mullen

Gregory Anthony Hrdlicka

Kathryn Hilpisch

Volkert A Zeijlemaker

Tom Dean Bennett

Paul A Sobotka

Laurie D Foerster

ShaileshKumar V Musley

Kevin P Vincent

Steven L Ning

Gerald A Portzline

John S Brandstetter

James Kevin Carney

Zhongping C Yang

William John Havel

Li Ping Wang

Mark L Brown

Thomas A Anderson

John D Wahlstrand

Paul Gordon Krause

Rick D McVenes

Teresa A Whitman

Brian Bruce Lee

Chad Giese

Paul J DeGroot

Kevin T Ousdigian

Charles R Gordon

Kevin Patrick Kuehn

Pooja Mehta

Lucy M Nichols

Ryan D Wyszynski

Mattias Rouw

Christopher D Koch

Yanzhu Zhao

Joel R Lauer

Michael C Brown

D'Anne E Kudlik

Grant Alan Neitzell

Becky L Dolan

Nirav Vijay Sheth

Michael William Kimmel

Gautham Rajagopal

Glenn C Zillmer

Lawrence C McClure

Linda L Ruetz

Srikara V Peelukhana

Wei Gan

Joshua J Blauer

Ven R Manda

Michael A Reinert

Scott A Ransom

Darrell J Swenson

Harold E Stone

Raylene Pitschneider

Brandon S Sparks

A system comprises processing circuitry and memory comprising program instructions that, when executed by the processing circuitry, cause the processing circuitry to: apply a first set of rules to first patient parameter data for a first determination of whether sudden cardiac arrest of a patient is detected; determine that a one or more context criteria of the first determination are satisfied; and in response to satisfaction of the context criteria, apply a second set of rules to second patient parameter data for a second determination of whether sudden cardiac arrest of the patient is detected. At least the second set of rules comprises a machine learning model, and the second patient parameter data comprises at least one patient parameter that is not included in the first patient parameter data.

Acute health event monitoring

An intracardiac ventricular pacemaker is configured to detect a ventricular diastolic event from a motion signal received by a pacemaker control circuit from a motion sensor. The control circuit starts an atrial refractory period having an expiration time set based on a time of the detection of the ventricular diastolic event. The control circuit detects an atrial systolic event from the motion signal after expiration of the atrial refractory period and controls a pulse generator of the pacemaker to deliver a pacing pulse to a ventricle of a patient's heart at a first atrioventricular pacing time interval after the atrial systolic event detection.

Atrial tracking in an intracardiac ventricular pacemaker

An intracardiac ventricular pacemaker having a motion sensor is configured to produce a motion signal including an atrial systolic event and a ventricular diastolic event indicating a passive ventricular filling phase, set a detection threshold to a first amplitude during an expected time interval of the ventricular diastolic event and to a second amplitude lower than the first amplitude after an expected time interval of the ventricular diastolic event. The pacemaker is configured to detect the atrial systolic event in response to the motion signal crossing the detection threshold and set an atrioventricular pacing interval in response to detecting the atrial systolic event.

An intracardiac pacemaker system is configured to produce physiological atrial event signals by a sensing circuit of a ventricular intracardiac pacemaker and select a first atrial event input as the physiological atrial event signals. The ventricular intracardiac pacemaker detects atrial events from the selected first atrial event input, determines if input switching criteria are met, and switches from the first atrial event input to a second atrial event input in response to the input switching criteria being met. The second atrial event input includes broadcast atrial event signals produced by a second implantable medical device and received by the ventricular intracardiac pacemaker.

Input switching in a ventricular intracardiac pacemaker

A controller for an implantable medical device including a housing sized and configured to be received within a patient, the housing having a thermally conductive shell defining an exterior surface. At least a portion of the exterior surface of the thermally conductive shell defines at least one from the group consisting of a plurality of corrugations and a plurality of protuberances.

Shield optimization for maximizing heat dissipation at the device tissue interface and improving fixation

A controller for an implantable blood pump, includes an accelerometer configured to measure at least one from the group consisting of position and movement of the controller. Processing circuitry is configured to control operation of the implantable blood pump, the processing circuitry being in communication with the accelerometer, the processing circuitry being configured to adjust a speed of the implantable blood pump if the measured at least one from the group consisting of position and movement deviates from a respective predetermined threshold.

Body position and activity based flow control for ventricular assist device (VAD) with fully implantable controller

Techniques for minimizing rate of depletion of a non-rechargeable power source, to extend the operational lifetime of an implantable medical device that includes the non-rechargeable power source, by enforcing operational-mode-specific communication protocols whereby inter-device communication between the implantable medical device and another implantable medical device is such that level of power draw from the non-rechargeable power source by the implantable medical device is less than level of power draw from the rechargeable power source by the another implantable medical device for the implantable medical devices to engage in communication with each other.

Power management for implantable medical device systems

A method of detecting sleep apnea includes generating a cardiac signal indicating activity of a heart of a patient. The method further includes determining a short-term average heart rate and a long-term average heart rate. The method further includes determining a start and end of a heart rate cycle based on the short-term average heart rate and the long-term average heart rate. The method further includes determining physiological parameter values occurring during the heart rate cycle. The method further includes determining whether patient has or has not experienced a sleep apnea event based on whether one or more conditions are satisfied by one or more parameter values for one or more heart rate cycles and responsively generating an indication that patient has or has not experienced a sleep apnea event.

Detection and monitoring of sleep apnea conditions

Systems and methods include differential diagnosis for acute heart failure to provide treatment to a patient including determining whether the patient has cardiac volume overload, determining whether the patient has decreased abdominal venous system volume, and providing the appropriate treatment in response to the determinations. A multi-sensor system may be used to determine cardiac volume and abdominal venous system volume. Fluid redistribution treatment may be provided when cardiac volume overload is accompanied by a decrease in abdominal venous system volume. Fluid accumulation treatment may be provided when cardiac volume overload is not accompanied by a decrease in abdominal venous system volume.

Acute heart failure monitoring and treatment

A method and implantable medical device system for delivering a left ventricular (LV) cardiac pacing therapy via a single-pass coronary sinus lead and sensing far-field cardiac signals via one or more far-field sensing vectors formed between the plurality of electrodes. Beat morphologies corresponding to the far-field cardiac signals are determined, and a beat morphology match between each of the far-field beat morphologies and an intrinsic beat morphology template is determined so that one of loss of LV capture, pseudo fusion and loss of synchrony is determined in response to the determined beat morphology match. One of a loss of capture adjustment, a pseudo fusion adjustment, and a resynchronization adjustment is performed in response to the determined one of loss of LV capture, pseudo fusion and loss of synchrony in response to the determined beat morphology match to generate an adjusted LV cardiac pacing therapy.

Left ventricular capture and synchronization verification using a single multi-electrode coronary sinus lead

A device and method are described for transmitting tissue conductance communication (TCC) signals. A device may be is configured to establish a transmission window by transmitting a TCC test signal at multiple time points over a transmission test period to a receiving device and detect at least one response to the transmitted TCC test signals performed by the receiving device. The IMD is configured to establish the transmission window based on the at least one detected response so that the transmission window is correlated to a time of relative increased transimpedance between a transmitting electrode vector and receiving electrode vector during the transmission test period.

Device, system and method with adaptive timing for tissue conduction communication transmission

A method and implantable medical device system for delivering a cardiac pacing therapy that includes suspending delivery of the LV cardiac pacing therapy and sensing far-field cardiac signals via one or more far-field sensing vectors formed between a plurality of electrodes positioned on a single-pass coronary sinus lead. Far-field signal features are determined in response to the sensed far-field cardiac signals, a first offset interval and a second offset interval are determined in response to the determined far-field signal features, and an AV delay of the LV cardiac pacing therapy is adjusted in response to the determined first offset interval and second offset interval. Delivery of the LV cardiac pacing therapy having the adjusted AV delay is subsequently resumed.

Adaptive cardiac resynchronization therapy using a single multi-electrode coronary sinus lead

Input switching in a ventricular pacemaker

Growing community of inventors

Maple Grove, MN, United States of America

Yong Kyun Cho